Literature DB >> 19406596

Non-invasive assessment of hepatic fat accumulation in chronic hepatitis C by 1H magnetic resonance spectroscopy.

Martin Krssák1, Harald Hofer, Fritz Wrba, Martin Meyerspeer, Attila Brehm, Alfred Lohninger, Petra Steindl-Munda, Ewald Moser, Peter Ferenci, Michael Roden.   

Abstract

BACKGROUND: Liver biopsy is the standard method for diagnosis of hepatic steatosis, but is invasive and carries some risk of morbidity. AIMS AND METHODS: Quantification of hepatocellular lipid content (HCL) with non-invasive single voxel (1)H magnetic resonance spectroscopy (MRS) at 3T was compared with histological grading and biochemical analysis of liver biopsies in 29 patients with chronic hepatitis C. Body mass index, indices of insulin resistance (homeostasis model assessment index, HOMA-IR), serum lipids and serum liver transaminases were also quantified.
RESULTS: HCL as assessed by (1)H MRS linearly correlated (r=0.70, p<0.001) with histological evaluation of liver biopsies and was in agreement with histological steatosis staging in 65% of the patients. Biochemically assessed hepatic triglyceride contents correlated with HCL measured with (1)H MRS (r=0.63, p<0.03) and allowed discriminating between none or mild steatosis versus moderate or severe steatosis. Patients infected with hepatitis C virus genotype 3 had a higher prevalence of steatosis (62%) which was not explained by differences in body mass or whole body insulin resistance. When these patients were excluded from correlation analysis, hepatic fat accumulation positively correlated with insulin resistance in the remaining hepatitis C patients (HCL vs. HOMA-IR, r=0.559, p<0.020, n=17).
CONCLUSION: Localized (1)H MRS is a valid and useful method for quantification of HCL content in patients with chronic hepatitis C and can be easily applied to non-invasively monitoring of steatosis during repeated follow-up measurements in a clinical setting. Copyright (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406596     DOI: 10.1016/j.ejrad.2009.03.062

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  17 in total

1.  The effect of water suppression on the hepatic lipid quantification, as assessed by the LCModel, in a preclinical and clinical scenario.

Authors:  Amandine Coum; Fanny Noury; Elise Bannier; Karima Begriche; Bernard Fromenty; Yves Gandon; Hervé Saint-Jalmes; Giulio Gambarota
Journal:  MAGMA       Date:  2015-11-21       Impact factor: 2.310

2.  MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients.

Authors:  Milan Hájek; Monika Dezortová; Dita Wagnerová; Antonín Skoch; Luděk Voska; Irena Hejlová; Pavel Trunečka
Journal:  MAGMA       Date:  2011-07-10       Impact factor: 2.310

3.  Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic steatosis.

Authors:  Patrick Georgoff; David Thomasson; Adeline Louie; Estee Fleischman; Lauren Dutcher; Haresh Mani; Shyamasundaran Kottilil; Caryn Morse; Lori Dodd; David Kleiner; Colleen Hadigan
Journal:  AJR Am J Roentgenol       Date:  2012-07       Impact factor: 3.959

4.  Pancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans.

Authors:  Paul Begovatz; Chrysi Koliaki; Katharina Weber; Klaus Strassburger; Bettina Nowotny; Peter Nowotny; Karsten Müssig; Jürgen Bunke; Giovanni Pacini; Julia Szendrödi; Michael Roden
Journal:  Diabetologia       Date:  2015-03-05       Impact factor: 10.122

Review 5.  Intracellular lipid accumulation and shift during diabetes progression.

Authors:  Peter Wolf; Yvonne Winhofer; Christian-Heinz Anderwald; Martin Krššák; Michael Krebs
Journal:  Wien Med Wochenschr       Date:  2014-07-22

6.  Liver metabolite concentrations measured with 1H MR spectroscopy.

Authors:  Ronald Ouwerkerk; Roderic I Pettigrew; Ahmed M Gharib
Journal:  Radiology       Date:  2012-08-13       Impact factor: 11.105

7.  Circulating sCD36 levels in patients with non-alcoholic fatty liver disease and controls.

Authors:  S Heebøll; M K Poulsen; M J Ornstrup; T N Kjær; S B Pedersen; S Nielsen; H Grønbæk; A Handberg
Journal:  Int J Obes (Lond)       Date:  2016-12-05       Impact factor: 5.095

Review 8.  Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age?

Authors:  Gábor Firneisz
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

9.  Initial clinical application of modified Dixon with flexible echo times: hepatic and pancreatic fat assessments in comparison with (1)H MRS.

Authors:  Roshan S Livingstone; Paul Begovatz; Sabine Kahl; Bettina Nowotny; Klaus Strassburger; Guido Giani; Jürgen Bunke; Michael Roden; Jong-Hee Hwang
Journal:  MAGMA       Date:  2013-12-04       Impact factor: 2.310

10.  Application of localized ³¹P MRS saturation transfer at 7 T for measurement of ATP metabolism in the liver: reproducibility and initial clinical application in patients with non-alcoholic fatty liver disease.

Authors:  Ladislav Valkovič; Martin Gajdošík; Stefan Traussnigg; Peter Wolf; Marek Chmelík; Christian Kienbacher; Wolfgang Bogner; Michael Krebs; Michael Trauner; Siegfried Trattnig; Martin Krššák
Journal:  Eur Radiol       Date:  2014-03-20       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.